Inhibition of GNNQQNY prion peptide aggregation by trehalose: a mechanistic view

Nidhi Katyal1, Shashank Deep1

  • 1Department of Chemistry, Indian Institute of Technology, Delhi, Hauzkhas, New Delhi, India. sdeep@chemistry.iitd.ac.in.

Insights

Trehalose, a known aggregation inhibitor, delays amyloid fibril formation by increasing activation barriers. This small molecule modulates the aggregation pathway of the GNNQQNY peptide, impacting neurodegenerative disease pathogenesis.

Area of Science:

  • Biochemistry
  • Computational Biology
  • Neuroscience

Background:

  • Amyloid fibril deposition is central to neurodegenerative diseases.
  • Early aggregation stages involve toxic oligomer formation.
  • Small molecular ligands are potential therapeutic agents to inhibit aggregation.

Purpose of the Study:

  • To investigate the kinetics of GNNQQNY peptide aggregation.
  • To elucidate the mechanism by which trehalose inhibits aggregation.
  • To provide mechanistic insights into aggregation modulation.

Main Methods:

  • All-atom molecular dynamics (MD) simulations with explicit solvent.
  • Principal Component Analysis (PCA) of 26 properties.
  • Analysis of peptide aggregation kinetics and conformational changes.

Main Results:

  • Trehalose increases activation barriers for aggregate formation, delaying the process.
  • Trehalose promotes the sampling of small aggregates lacking beta-sheet conformation.
  • The predominant growth route shifts from monomer addition to condensation in the presence of trehalose.
  • Trehalose-mediated water expulsion influences aggregate morphology and assembly entropy.

Conclusions:

  • Trehalose effectively modulates the GNNQQNY peptide aggregation pathway.
  • The mechanism involves increasing activation barriers and altering growth kinetics.
  • Water molecules play a significant role in aggregate formation and morphology.